Xilio Therapeutics Inc is a clinical-stage biotechnology company focused on discovering and developing masked immuno-oncology (I-O) therapies to improve outcomes for people living with cancer. Leveraging its clinically validated masking technology and capabilities, the company develops I-O therapies designed to selectively activate within the tumor microenvironment to achieve durable efficacy without the severe side effects associated with systemically active I-O agents. Its integrated biology and protein engineering approach enables the design and development of potent masked biologics that are activated by tumor-specific proteases.

What symbol and exchange does Xilio Therapeutics shares trade?

Xilio Therapeutics trades on the NASDAQ stock market under the symbol XLO.

What is Xilio Therapeutics stock price doing today?

As of November 9, 2026, XLO stock price climbed to $8.75 with 2,384 million shares trading.

What is Xilio Therapeutics's Beta?

XLO has a beta of -0.04, meaning it tends to be less sensitive to market movements. XLO has a correlation of 0.00 to the broad based SPY ETF.

How much is Xilio Therapeutics worth?

XLO has a market cap of $57.53 million. This is considered a Micro Cap stock.

How much money does Xilio Therapeutics make?

Last quarter Xilio Therapeutics reported $19 million in Revenue and -$.33 earnings per share. This beat revenue expectation by $6 million and exceeded earnings estimates by $.26.

What is the highest and lowest price Xilio Therapeutics traded in the last 3 year period?

In the last 3 years, XLO traded as high as $29.96 and as low as $6.47.

What are the top ETFs holding Xilio Therapeutics?

The top ETF exchange traded funds that XLO belongs to (by Net Assets): VTI, VXF, IWC, DXUV, DCOR.

Is Xilio Therapeutics (XLO) a good investment?

XLO has underperformed the market in the last year with a return of -24.8%, while the SPY ETF gained +13.4%. In the last 3 month period, XLO fell short of the market, returning -5.6%, while SPY returned -1.9%. However, in the most recent 2 weeks XLO has outperformed the stock market by returning +15.6%, while SPY returned -1.0%.

What are the support and resistance levels for Xilio Therapeutics (XLO)?

XLO support price is $8.00 and resistance is $9.24 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that XLO shares will trade within this expected range on the day.